Taftefet (טפטפת): Where Should Israel’s Next Drop Go?
In 1959, Israeli water engineer Simcha Blass and his son Yeshayahu developed a basic drip-irrigation system they called Taftefet (טפטפת), Hebrew for “dripper.” Its purpose was elegantly simple. It released small amounts of water slowly and precisely, close to where a plant could actually use it.
That breakthrough helped transform global agriculture.
What made drip irrigation innovative was not simply that it used less water. It changed how water was delivered. Rather than watering a broad area, it directed controlled amounts close to plant roots.
Not every plant needs the same amount of water. And those needs can change as a plant grows.
The principle is simple: the right amount, in the right place, at the right time.
There may be a lesson here for Israeli biomedical innovation.
Israel’s universities and research institutions regularly produce discoveries with therapeutic potential. But turning a promising discovery into a medicine requires scarce resources: capital, translational and development expertise, manufacturing capabilities, regulatory strategy, clinical resources and time.
The challenge is not simply to provide more. It is to provide what is needed, where it is needed and when it is needed.
Discoveries, like plants, may need different amounts of support at different stages. In biomedical development, that support can also take different forms.
One discovery may need stronger biological validation. Another may need translational work. A third may need clinical development expertise, manufacturing support or the right industry partner.
What matters is matching the resource to the discovery and the stage it has reached.
Taftefet did not create more water. It created a better way to use the water that was available.
Biomedical innovation faces a similar challenge.
The opportunity is to direct available resources with greater precision, adding the right support at the critical moments when it can make the greatest difference.
Israel once helped change agriculture by answering a fundamental question: where should the next drop go?
Biomedical innovation should ask the same question.
The right resource. The right discovery. The right time.
